Bain Capital Specialty Finance (STU:618) Research & Development: €0.00 Mil (TTM As of Mar. 2026)


STU:618 Bain Capital Specialty Finance Inc STU:618
65 GF Score
Price €10.50
GF Value €8.90
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bain Capital Specialty Finance Research & Development?

Bain Capital Specialty Finance STU:618 65 Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus rates STU:618 with a GF Score™ of 65/100 and a GF Value™ of €8.90 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Bain Capital Specialty Finance's Research & Development for the three months ended in Mar. 2026 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00 Mil.

Bain Capital Specialty Finance  (STU:618) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Bain Capital Specialty Finance Research & Development Related Terms

Bain Capital Specialty Finance Research & Development Historical Data

* Premium members only.

The historical data trend for Bain Capital Specialty Finance's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bain Capital Specialty Finance Research & Development Chart

Bain Capital Specialty Finance Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bain Capital Specialty Finance Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:618
65GF Score
Bain Capital Specialty Finance Inc STU:618
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bain Capital Specialty Finance Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Bain Capital Specialty Finance (STU:618) has a Research & Development of €0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Bain Capital Specialty Finance and its competitors.
Is Bain Capital Specialty Finance's Research & Development too high?
Bain Capital Specialty Finance's current Research & Development is €0.00 Mil. Overall, Bain Capital Specialty Finance has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bain Capital Specialty Finance's Research & Development compare to PCN and PHK?
Bain Capital Specialty Finance's Research & Development of €0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Bain Capital Specialty Finance and its competitors. Bain Capital Specialty Finance's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bain Capital Specialty Finance stock overvalued right now?
Based on GuruFocus' analysis, Bain Capital Specialty Finance (STU:618) is currently considered Modestly Overvalued. The stock's GF Value™ is €8.90, compared to a current price of €10.50 — trading 18% above its estimated fair value. The current Research & Development is €0.00 Mil. Bain Capital Specialty Finance's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Bain Capital Specialty Finance (STU:618), the current Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bain Capital Specialty Finance (STU:618) Overvalued in 2026?

Based on GuruFocus' analysis, Bain Capital Specialty Finance stock appears to be overvalued. The current stock price of €10.50 is trading 18% above its estimated GF Value™ of €8.90. GuruFocus considers Bain Capital Specialty Finance to be Modestly Overvalued.

Key valuation signals for STU:618:

  • Research & Development: €0.00 Mil
  • GF Value™: €8.90 vs. price of €10.50 (18% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the STU:618 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bain Capital Specialty Finance Business Description

Other Exchanges BCSF:USA
Address 200 Clarendon Street, 37th Floor, Boston, MA, USA, 02116
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing in middle-market companies. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan, and others.
65GF Score

Get the complete analysis for STU:618

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.50
Price
€8.90
GF Value